home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 20, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

Charles River Biopharmaceutical Services GmbH

Max-Planck-Strasse 15A
Erkrath, 40699 GERMANY
Germany

Phone: +49-211-9255-300
Fax: +49-211-9255-333

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Charles River Biopharmaceutical Services GmbH is a leading specialist for contract quality control on biotechnically produced pharmaceuticals and blood derived products located in Germany, Duesseldorf and Cologne. The company is GLP-certified (Good Laboratory Practice) and works in compliance with the current guidelines and recommendations issued by ICH, EMEA and FDA. Compliance with these established and recognised quality standards has been re-verified in numerous audits conducted by our clients. With a background of years of co-operation with renowned pharmaceutical companies such as Aventis AG, Roche AG and Bayer AG we can draw on a wealth of day to day practical experience.

Technology/Services Portfolio
The company continuously fills up its range of service. The development of a biotechnically produced pharmaceutical can now be supported from its start in cellbanking through the monitoring and clearance-validation of contaminants during down-stream-processing down to the release testing of the final product.

Special expertise:
cell line characterization and safety testing of prokaryotic and eukaryotic cell banks (MCB, WCB, EPC/PPCB and bulk harvest)
process evaluation for
- viruses and prions (inactivation or removal)
- impurities (residual DNA, host cell proteins, media components, ...)
- contaminants (adventitious viruses, mycoplasma, endotoxins, ...)
protein chemistry
- product characterization (identity, purity, integrity)
- lot release testing
bioassays
plasmid analysis and DNA sequencing according to GLP
stability testing
- proteins
- plasmids
development of production processes in mammalian cell cultures

This portfolio in biopharmaceutical quality control provides a unique position within the field of contractors in Germany and Europe alike. Large pharmaceutical producers frequently use the strong proficiency in biotech specific methods. Small biotech development companies benefit additionally.



Selected Categories:
Product Company   Service Company
Biotech
- General
Pharmaceutical
- General
Contract
- Services
Laboratory
- Analytical

Last update of this entry: October 26, 2010

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.